Alzheimer’s Disease|OMICS International|Alzheimer's Disease And Parkinsonism

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Magnetic Resonance Imaging Open Access Journals

Alzheimer disease (AD) is a progressive neurodegenerative disease with an insidious onset that is difficult to distinguish from normal aging especially in its earliest stages. It typically begins with a subtle impairment of memory that evolves into the amnestic form of mild cognitive impairment (aMCI). As the disease continues to progress, other cognitive domains become affected and a full dementia state becomes apparent. In order to better understand this disease and to develop effective treatments for it, biomarkers are needed to identify the stages of normal aging, MCI, and AD and predict future cognitive decline. Open access Journal is an International peer-reviewed journal which publishes research in all the fields of Alzheimer’s Disease & Parkinsonism. This journal gives a universal discussion to the production of papers in the regions of Alzheimer’s Disease, Parkinsonism.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on January, 2021